PeptideOS
← Library

SLU-PP-332

Small-molecule ERR (estrogen-related receptor) agonist / exercise mimetic

Also known as: ERR pan-agonist (ERRα/β/γ)

Tier 3, Preclinical only

Evidence is limited to animal or in-vitro work. No human pharmacokinetics. Any human dose in circulation is extrapolated, and extrapolation across species routinely fails.

Half-life
Not established

No validated pharmacokinetic half-life located in an allowed primary source.

Dosing
No established dose

No established human dose. Mouse studies use body-weight-based (mg/kg) injection dosing; not standardized. Kept qualitative per instructions.

Regulatory status
Not approved. Preclinical research compound (ERRα/β/γ agonist).
Evidence base
animal only · confidence: low

Mouse metabolic-syndrome/obesity studies only; no human data. Molecular weight NOT reported: PubChem name lookup returned an ambiguous/conflicting entry (CID 5338394, C18H14N2O2, 290.3) that does not match the published ERR-agonist structure, so no MW is asserted.

Safety

No human safety data. Preclinical only; safety in humans unestablished. Not for clinical dosing decisions.